2013
DOI: 10.4067/s0034-98872013000800015
|View full text |Cite
|
Sign up to set email alerts
|

Neurofibromatosis type I and anti-phospholipid antibody syndrome: Report of one case

Abstract: Neurofibromatosis type I (NF1) has been only rarely reported in association with anti-phospholipid syndrome (APS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Involvement of the skin, bone, soft tissue, arterial system and nervous system is accompanied by multiple sclerosis and malignancy development in various organs and tissues of the body. Association with APS that causes thrombotic disorders has also been reported (8).…”
Section: Discussionmentioning
confidence: 99%
“…Involvement of the skin, bone, soft tissue, arterial system and nervous system is accompanied by multiple sclerosis and malignancy development in various organs and tissues of the body. Association with APS that causes thrombotic disorders has also been reported (8).…”
Section: Discussionmentioning
confidence: 99%
“…An association of NF1 and APS, a prothrombotic autoimmune disease, is unusually rare. Very few documented cases fulfill the accepted criteria for a diagnosis of APS (Table 1) (4)(5)(6) . The currently accepted criteria for defining APS are the presence of at least one clinical criterion: ≥1 thromboembolic episodes and/or pregnancy morbidity or spontaneous fetal loss and at least one laboratory criterion: presence of lupus anticoagulant (LA), anticardiolipin antibody or anti-β 2 -glycoprotein 1 (IgG and IgM) on two occasions separated by 12 weeks.…”
Section: Discussionmentioning
confidence: 99%